- Home
- CI
as 05-09-2025 3:33pm EST
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.
| Founded: | 1792 | Country: | United States |
| Employees: | N/A | City: | BLOOMFIELD |
| Market Cap: | 81.7B | IPO Year: | N/A |
| Target Price: | $384.29 | AVG Volume (30 days): | 1.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 17 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 17.99 | EPS Growth: | 46.10 |
| 52 Week Low/High: | $262.03 - $370.83 | Next Earning Date: | 05-02-2025 |
| Revenue: | $255,368,000,000 | Revenue Growth: | 23.96% |
| Revenue Growth (this year): | 5.06% | Revenue Growth (next year): | 4.65% |
Stock Insider Trading Activity of The Cigna Group (CI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Granger Elder | CI | Director | Mar 14 '25 | Sell | $310.35 | 2,376 | $737,391.60 | 5,471 | |
| Eder Noelle K | CI | See Remarks | Mar 7 '25 | Sell | $320.00 | 9,944 | $3,182,080.00 | 13,406 | |
| Cordani David | CI | Chairman & CEO | Feb 28 '25 | Sell | $308.12 | 26,527 | $8,173,499.24 | 127,767 | |
| Jones Nicole S | CI | See Remarks | Feb 28 '25 | Sell | $308.12 | 4,904 | $1,511,020.48 | 29,421 |
Latest The Cigna Group News
CI Breaking Stock News: Dive into CI Ticker-Specific Updates for Smart Investing
Simply Wall St.
9 hours ago
Cigna Group's (NYSE:CI) Performance Is Even Better Than Its Earnings Suggest
StockStory
15 hours ago
1 Cash-Producing Stock with Solid Fundamentals and 2 to Ignore
Insider Monkey
2 days ago
The Cigna Group (CI): Among the Cheap ESG Stocks to Buy According to Hedge Funds
Argus Research
3 days ago
CI: Lowering target price to $367.00
MT Newswires
3 days ago
RBC Capital Adjusts Cigna Group Price Target to $371 From $355
Investing.com
3 days ago
CFRA: Cigna Group ’faces industry-wide cost pressures’
MT Newswires
3 days ago
Guggenheim Adjusts Cigna Group Price Target to $388 From $384, Maintains Buy Rating
MT Newswires
3 days ago
Deutsche Bank Adjusts Cigna Group Price Target to $372 From $356, Maintains Buy Rating
Compare CI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CI The Cigna Group - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.